For example, for an immunotype with a pronounced pro-tumor profile in cancer, we can use immunotherapy, taking into account its unique features (such as the expression levels of specific molecules like CTLA-4, PD-1, Lag-3, etc. or need in monocytes reprogramming). This evidence concerns the gene CTLA4 and neoplasm.